Mills, Sarah
Donnan, Peter
Buchanan, Deans
Smith, Blair H.
Funding for this research was provided by:
Chief Scientist Office (caf_17_06)
Article History
Received: 8 February 2023
Accepted: 17 November 2023
First Online: 30 November 2023
Declarations
:
: This project was approved by the Tayside medical Science Centre (TASC) Tayside Research Ethics Committee (REC) (reference 14/ES/0015). All methods were performed in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki. No human participants were used in this study. Access to anonymised data was granted through the Health Informatics Centre (HIC) at the University of Dundee. All data were anonymised before use. Informed consent from the legal guardians of patients who were included in this study was obtained; in Scotland, for posthumous data, the legal guardian for data is the data controller and Caldicott Guardian. The Caldicott Guardian approval reference for this study is Caldicott/CSAppSM1952.
: Na.
: PD provides statistical support to the Scottish Medicines Consortium. The authors have declared no other competing interests